Phospho-HDAC2 (Ser394) Antibody

Shipped with Ice Packs
In Stock

Description

Functional Role of Ser394 Phosphorylation

  • Hypertrophy Regulation: Phosphorylation at Ser394 activates HDAC2 during cardiac hypertrophy, while basal activity is maintained by phosphorylation at Ser422/Ser424 .

  • Transcriptional Complex Dynamics:

    • Phosphorylated HDAC2 (Ser394) preferentially interacts with Krüppel-like factor 5 (Klf5), displacing retinoic acid receptor α (RARα) from transcriptional complexes .

    • This phosphorylation facilitates Klf5 deacetylation, reducing Klf5 binding to the p21 promoter and upregulating p21 expression .

Kinase Pathways

  • CK2α Dependency: Casein kinase 2α (CK2α) phosphorylates HDAC2 at Ser394 and Ser407. Inhibition of CK2α (e.g., with apigenin) abolishes HDAC2 phosphorylation and Klf5 deacetylation .

  • Am80-Induced Signaling: The synthetic retinoid Am80 activates CK2α, promoting HDAC2 phosphorylation and subsequent dissociation of Klf5 from gene promoters like p21 .

Specificity Assays

  • Lambda-Phosphatase Blocking: Immunolabeling is eliminated after lambda-phosphatase treatment, confirming phosphorylation dependency .

  • Cross-Reactivity: Reactivity observed in bovine, chicken, and non-human primates .

Key Protocols

  • Western Blot: Optimal detection at 1:1,000 dilution with protein lysates from tissues/cells treated with phosphorylation-inducing agents (e.g., okadaic acid) .

  • Immunoprecipitation: Used to study HDAC2 interactions with Klf5, RARα, or CK2α in vascular smooth muscle cells (VSMCs) .

Applications in Disease Research

  • Cardiovascular Disease: HDAC2 Ser394 phosphorylation is implicated in pathological cardiac remodeling .

  • Cancer and Epigenetics: HDAC2’s role in deacetylating histones and non-histone proteins (e.g., Klf5) links Ser394 phosphorylation to tumor suppression or oncogenesis, depending on cellular context .

Limitations and Considerations

  • Species Restrictions: Limited reactivity in non-mammalian models (e.g., zebrafish) .

  • Phospho-Specificity: Requires validation via parallel assays with non-phosphorylated HDAC2 controls .

Product Specs

Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your orders. Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery timelines.
Synonyms
D10Wsu179e antibody; HD 2 antibody; HD2 antibody; HDAC 2 antibody; Hdac2 antibody; HDAC2_HUMAN antibody; Histone deacetylase 2 (HD2) antibody; Histone deacetylase 2 antibody; OTTHUMP00000017046 antibody; OTTHUMP00000227077 antibody; OTTHUMP00000227078 antibody; RPD3 antibody; transcriptional regulator homolog RPD3 antibody; YAF1 antibody; YY1 associated factor 1 antibody; YY1 transcription factor binding protein antibody; Yy1bp antibody
Target Names
Uniprot No.

Target Background

Function
Phospho-HDAC2 (Ser394) Antibody is responsible for deacetylating lysine residues on the N-terminal part of the core histones (H2A, H2B, H3, and H4). Histone deacetylation serves as an epigenetic repression marker and plays a crucial role in transcriptional regulation, cell cycle progression, and developmental events. Histone deacetylases function by forming large multiprotein complexes. Phospho-HDAC2 (Ser394) Antibody forms transcriptional repressor complexes by associating with MAD, SIN3, YY1, and N-COR. It interacts during the late S-phase of DNA replication with DNMT1 within another transcriptional repressor complex comprising DNMT1, DMAP1, PCNA, and CAF1. Phospho-HDAC2 (Ser394) Antibody deacetylates TSHZ3 and regulates its transcriptional repressor activity. It is a component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, numerous genes implicated in multilineage blood cell development. It may be involved in the transcriptional repression of circadian target genes, such as PER1, mediated by CRY1 through histone deacetylation. Phospho-HDAC2 (Ser394) Antibody is implicated in MTA1-mediated transcriptional corepression of TFF1 and CDKN1A.
Gene References Into Functions
  1. Research has found that HDAC2 expression is upregulated in patients with chronic diabetic foot ulcer and in high glucose-induced endothelial progenitor cells. PMID: 30063937
  2. Comparative molecular docking studies of the lead RH01652 with class I HDACs (HDAC1, HDAC2, HDAC3, and HDAC8) show a higher binding affinity towards HDAC2. Therefore, lead RH01652 could serve as a template for designing novel and potent inhibitors of HDAC2. PMID: 29932788
  3. Human immortalized telencephalic/mesencephalic microglial cells reveal significant upregulation of HDAC2 in the presence of the potent microglial activator lipopolysaccharide. PMID: 29803514
  4. Studies have found that HDAC2 was the direct target of miR-31 by binding to 3'-UTR, as demonstrated by luciferase reporter assays, qRT-PCR, and western blotting. HDAC2 played an activating role in tumor growth, with its expression being upregulated and inversely associated with miR-31 levels. PMID: 29333444
  5. Data indicate that obesity impacts H4ac levels and that strenuous exercise leads to an enhanced chronic low-grade inflammation profile in obesity through an imbalance in H4ac/HDAC2. PMID: 29142617
  6. Knockdown of HDAC2 completely mimicked the effects of 1,25(OH)2D3 on PTEN gene expression. PMID: 28737824
  7. Muscle biopsies of chronic obstructive pulmonary disease (COPD) patients showed a significant correlation with HDAC2 decrease compared to controls. PMID: 28526090
  8. Using tissue microarrays of hepatocellular carcinoma (HCC) patients, researchers determined the prognostic values of the core genes in the network and found that RAD21, CDK1, and HDAC2 expression levels were negatively associated with overall survival for HCC patients. PMID: 28434945
  9. Combined treatment with the histone deacetylase inhibitors (HDACi) suberoylanilide hydroxamic acid plus 5-fluorouracil (5-FU) and oxaliplatin (Oxa) reduced the level of HDAC2 expression in HT-29 cells. PMID: 27283986
  10. miR-223 controls the expression of CX3CL1 by targeting HDAC2 in COPD patients and mouse models of the disease. PMID: 26864305
  11. Data demonstrate that BRCA2 was required for HDAC2/3 association with acetylated BubR1 in nocodazole (Noc)-arrested cells. PMID: 28985013
  12. A study identified two classes of HDAC2 targets in human cells, with a dependence of HDAC1 on HDAC2 at one class of targets, and distinguished unique functions for HDAC2. PMID: 28982113
  13. This research demonstrated that the expression of HDAC2 Transcript is reduced in the dorsolateral prefrontal cortex of patients with schizophrenia. PMID: 27959513
  14. The findings suggest that miR-455-3p plays a critical role during chondrogenesis by directly targeting HDAC2/8 and promoting histone H3 acetylation. PMID: 27638301
  15. The report details the interaction between CFTR and HDAC2, and its involvement in the development of Ph+ leukemia. PMID: 28235656
  16. USP4 inhibits p53 and NF-kappaB through deubiquitinating and stabilizing HDAC2. PMID: 26411366
  17. HDAC2 controls ciliogenesis independently of Kras, which facilitates Aurora A expression. These studies indicate that HDAC2 is a novel regulator of primary cilium formation in pancreatic ductal adenocarcinoma (PDAC) cells. PMID: 28028031
  18. The current findings implicate the HDAC2/miR-101/AMPK pathway as a critical mediator of Alzheimer's disease (AD) pathogenesis. These studies also highlight the importance of epigenetics in AD and provide novel therapeutic targets. PMID: 28202389
  19. HDAC2 upregulation is associated with hepatocellular carcinoma. PMID: 27342975
  20. Research suggests that HDAC2 can trigger migration and invasion of non-small cell lung carcinoma cells by activating NF-kappaB to up-regulate fibronectin expression. PMID: 27665474
  21. KLF4 acts as a tumor suppressor or oncogene to activate or repress target gene transcription depending on its acetylation status, which is regulated by p21 and CK2 interaction-mediated HDAC2 phosphorylation. PMID: 26729194
  22. Decreased HDAC2 expression is associated with cisplatin resistance in ovarian cancer. PMID: 26683361
  23. In cigarette smoke extract-exposed airway epithelial cells and macrophages, HDAC2 is excessively ubiquitinated and degraded in the proteasome, attributed to low expression of USP17. PMID: 26617781
  24. The results suggest that HDAC2 is involved in the transcriptional regulation of human odontoblasts in vivo. PMID: 22297573
  25. Endothelial-Mesenchymal Transition is initiated by the recruitment of aberrantly phosphorylated DNMT1 to the RASAL1 CpG island promoter by HDAC2, causing aberrant promoter methylation and transcriptional suppression. PMID: 26815200
  26. Selective inhibition of HDAC2 in lung tumor cells causes survivin downregulation through activation of p53, which is mediated by downregulation of Mdm2. PMID: 25605253
  27. A study revealed that HDAC2 is overexpressed in colorectal cancer (CRC) cells; its knockdown can increase the sensitivity of CRC cells to doxorubicin via upregulation of ABCB1. PMID: 26846508
  28. Pancreatic adenocarcinoma patients with enhanced HDAC-1 and -6 expression showed significantly longer survival times compared to those with low expression, while a borderline association concerning HDAC-2 expression was noted. PMID: 26502922
  29. Lymphocyte senescence in COPD is associated with loss of HDAC2 in CD28nullCD8+ T and NKT-like cells. PMID: 26498345
  30. HDAC2 may not confer susceptibility to schizophrenia in the Han Chinese population. PMID: 26063464
  31. In endothelial dysfunction, HDAC2 levels were reciprocally regulated by ectopic expression of NEDD8 and the de-NEDDylating enzyme SENP8. PMID: 25655932
  32. Aberrant overexpression of HDACs in basal cells of idiopathic pulmonary fibrosis (IPF) lungs may contribute to the bronchiolisation process in this disease. Similarly, generation and apoptosis resistance of IPF fibroblasts are mediated by enhanced activity of HDAC enzymes. PMID: 26359372
  33. HDAC2 sumoylation is important for NF-kappaB-dependent gene expression and for the resistance of cells against stress. PMID: 25704882
  34. HDAC2 inhibition reduces proliferation and induces apoptosis via the caspase-dependent pathway in human glioma cell lines, possibly by activating the p53 signaling pathway. PMID: 25523932
  35. Data indicate that histone deacetylase 2 (HDAC2) has a specific role in leukemogenesis. PMID: 25473896
  36. HDAC3 is an essential target to disrupt HIV-1 latency, and inhibition of HDAC2 may also contribute to the effort to purge and eradicate latent HIV-1 infection. PMID: 25136952
  37. BRG1/HDAC2 and beta-catenin constitute a manipulative apparatus at the transcription start site to play opposite but complementary roles in regulating hTERT expression. PMID: 25486475
  38. HDAC2 plays a central role in coupling lysine acetylation to synaptic plasticity and mediates many of the effects of HDAC inhibition in cognition and disease. PMID: 25492968
  39. Data suggest that p15RS (p15INK4b-related sequence) acts as an intrinsic transcriptional repressor for Wnt/beta-catenin-mediated gene transcription through recruiting HDAC2 histone deacetylase. PMID: 25697359
  40. Simultaneous loss of Hdac1 and Hdac2 resulted in loss of hematopoietic stem cells. PMID: 24763403
  41. Research indicated that cPA may have beneficial effects in inflammation-related cardiovascular disease by controlling HDAC2 regulation. PMID: 25013374
  42. HDAC2 silencing in HCC cells also strongly inhibited PPARgamma signaling. PMID: 24958469
  43. Inhibition of cell growth by melittin might be led by HDAC2-mediated PTEN upregulation, Akt inactivation, and inhibition of the PI3K/Akt signaling pathways. PMID: 24788349
  44. Osteocalcin levels were decreased, an effect induced at the transcriptional level, and were strongly correlated with inhibition of HDAC2. PMID: 24105979
  45. These results indicated the potential of specific inhibition of HDAC2 by small molecular chemicals for future therapeutic agents in human renal cancer treatment. PMID: 24390319
  46. The proliferation inhibition and cell cycle arrest mediated by downregulated HDAC2 expression may be tightly associated with the decrease of cyclin D1, cyclin E, and cdk2 protein expression. PMID: 24965412
  47. PELP1 regulates tumor metastasis by controlling the expression and functions of the tumor metastasis suppressors miR-200a and miR-141. PMID: 23975430
  48. HDAC2 is a critical regulator of Arg2 expression and thereby endothelial nitric oxide and endothelial function. PMID: 24833798
  49. Data indicate prominent changes in urothelial cancer cell lines (UCC) were HDAC2 and/or HDAC8 up-regulation. PMID: 22944197
  50. A study found no association between HDAC2/HDAC3 gene polymorphisms and schizophrenia in the Chinese Han population. PMID: 23857786

Show More

Hide All

Database Links

HGNC: 4853

OMIM: 605164

KEGG: hsa:3066

STRING: 9606.ENSP00000430432

UniGene: Hs.3352

Protein Families
Histone deacetylase family, HD type 1 subfamily
Subcellular Location
Nucleus. Cytoplasm.
Tissue Specificity
Widely expressed; lower levels in brain and lung.

Q&A

What is the Phospho-HDAC2 (Ser394) Antibody and what are its basic applications?

Phospho-HDAC2 (Ser394) Antibody is a rabbit polyclonal antibody specifically designed to detect HDAC2 (Histone deacetylase 2) protein only when phosphorylated at serine 394. This antibody has demonstrated reactivity with human, mouse, and rat samples, making it versatile for cross-species research applications. The primary applications include Western Blot (WB) and immunofluorescence/immunocytochemistry (IF/ICC), with some variants also suitable for ELISA-based detection systems . The antibody is particularly valuable for researchers investigating epigenetic regulation mechanisms, as HDAC2 plays a crucial role in histone deacetylation processes that influence gene expression patterns.

What is the significance of HDAC2 phosphorylation at Ser394 in cellular functions?

Phosphorylation of HDAC2 at Ser394 represents a critical post-translational modification that significantly alters the protein's functional properties. Research has demonstrated that this specific phosphorylation event is associated with reduced deacetylase activity of HDAC2 . The modification at Ser394 has paradoxical effects - while decreasing HDAC2's enzymatic activity, it simultaneously enhances HDAC2's capacity to form co-repressor complexes, interact with transcription factors, recruit CREB-binding protein (CBP), and undergo acetylation on lysine residues . These combined effects ultimately lead to increased transrepression activity, suggesting that phosphorylation at Ser394 serves as a regulatory switch that repurposes HDAC2 function rather than simply activating or deactivating the protein.

How do I properly store and handle Phospho-HDAC2 (Ser394) Antibody for optimal results?

For optimal antibody performance and longevity, store Phospho-HDAC2 (Ser394) Antibody at -20°C for up to one year from the receipt date. The antibody is typically formulated in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide to maintain stability . Avoid repeated freeze-thaw cycles as they can degrade antibody quality and compromise experimental results. When working with the antibody, maintain cold chain conditions and aliquot the stock solution into smaller volumes for single-use applications. Before each experiment, briefly centrifuge the antibody vial to collect the solution at the bottom of the tube. For Western blot applications, dilution ranges typically fall between 1:500-1:2000, while ELISA applications may require more dilute preparations (approximately 1:20000) . Always optimize the antibody concentration for your specific experimental conditions and cell types.

What are the recommended protocols for detecting phosphorylated HDAC2 (Ser394) in cell culture experiments?

To effectively detect phosphorylated HDAC2 at Ser394 in cell culture experiments, researchers should implement a systematic approach combining cell preparation, treatment, and detection methods. Begin by seeding cells (e.g., H292 or similar cell lines) at a density of 3.0-5.0 × 10^5 cells in 6-well culture plates containing appropriate medium (such as RPMI-1640 with 10% FBS without antibiotics) and allow attachment overnight . For experiments investigating factors affecting HDAC2 phosphorylation, treat cells with relevant stimuli - for example, cigarette smoke extract (CSE) at 2.5% for specific time intervals (0.5h, 2h, 6h) has been used to induce phosphorylation changes .

For protein extraction, lyse cells in buffer containing phosphatase inhibitors (typically 0.5% NP-40, 25 mM Tris, 100 mM NaCl, pH 7.4) for 30 minutes on ice . Separate proteins by SDS-PAGE and transfer to PVDF membranes for immunoblotting with Phospho-HDAC2 (Ser394) antibody (typical dilution 1:500-1:2000) . For increased specificity, consider enriching phosphorylated HDAC2 through immunoprecipitation before Western blotting. For quantitative assessment of phosphorylation levels, colorimetric cell-based ELISA kits specific for Phospho-HDAC2 (Ser394) can provide high sensitivity detection across a range of >5000 cells .

How can I effectively use transfection methods to study HDAC2 phosphorylation at Ser394?

For transfection-based studies of HDAC2 phosphorylation at Ser394, prepare cells at appropriate density (4 × 10^6 cells in 100 mm dishes containing 7 ml of RPMI-1640 with 10% FBS without antibiotics) and allow overnight attachment . The following day, transiently transfect cells with expression vectors containing wild-type HDAC2 (1-488), or mutant constructs such as S394A (where serine is replaced with alanine to prevent phosphorylation) or multiple mutants like S394/422/424A .

For optimal transfection efficiency, use Lipofectamine 2000 according to the manufacturer's protocol with 4-8 μg of plasmid DNA. For co-transfection experiments (e.g., with CBP or CBP mutants lacking HAT activity), ensure equal total DNA amounts across all conditions by supplementing with empty vector plasmids . After 24 hours of transfection, treat cells with relevant stimuli to induce phosphorylation. For subsequent analysis, perform immunoprecipitation using anti-flag antibodies if flag-tagged HDAC2 constructs were used, followed by Western blotting with phospho-specific antibodies to detect the phosphorylation status at Ser394.

For knockdown studies to investigate kinases involved in HDAC2 phosphorylation, transfect cells with 100 pmol of relevant siRNAs (e.g., CK2α siRNA) for 24 hours before introducing HDAC2 expression constructs . This sequential transfection approach helps establish the relationship between specific kinases and HDAC2 phosphorylation at Ser394.

What controls should be included when studying HDAC2 phosphorylation at Ser394?

When studying HDAC2 phosphorylation at Ser394, a comprehensive set of controls is essential for result validation. Include the following controls:

  • Positive and negative phosphorylation controls: Treat cells with known phosphorylation inducers like okadaic acid (100 nM, 1h) as a positive control . Untreated cells serve as negative controls.

  • Antibody specificity controls: Include samples from cells expressing HDAC2 mutants where Ser394 is replaced with alanine (S394A) to confirm antibody specificity for the phosphorylated residue .

  • Total HDAC2 detection: Always probe for total HDAC2 levels alongside phospho-specific detection to normalize phosphorylation signals and account for expression level variations.

  • Pathway validation controls: When studying the kinases responsible for Ser394 phosphorylation, include controls where the suspected kinase (CK2α) is inhibited pharmaceutically or through siRNA-mediated knockdown .

  • Multiple mutant controls: Compare single S394A mutants with multiple mutants (S394/422/424A) to distinguish the specific contribution of Ser394 phosphorylation from other phosphorylation events .

  • Transfection controls: For transfection experiments, include empty vector controls and GFP expression constructs to monitor transfection efficiency and control for non-specific effects of the transfection procedure .

How does protein kinase CK2-mediated phosphorylation of HDAC2 at Ser394 regulate its deacetylase activity?

Protein kinase CK2-mediated phosphorylation of HDAC2 at Ser394 establishes a sophisticated regulatory mechanism that inversely correlates with deacetylase activity. Research has demonstrated that this phosphorylation event significantly reduces HDAC2's enzymatic activity toward histone substrates . The mechanism involves direct interaction between HDAC2 and serine-phosphorylated protein kinase CK2α, suggesting a specific molecular recognition process rather than random kinase-substrate interactions .

Paradoxically, while phosphorylation diminishes HDAC2's deacetylase function, it simultaneously enhances the protein's capacity to form co-repressor complexes and interact with transcription factors. This phosphorylation facilitates HDAC2 recruitment of CREB-binding protein (CBP), which subsequently catalyzes acetylation of HDAC2 on lysine residues . This phospho-acetylation dual modification creates a functionally distinct version of HDAC2 with increased transrepression activity despite reduced catalytic function.

To effectively study this regulatory mechanism, researchers should implement CK2α knockdown experiments using specific siRNAs, followed by assessment of HDAC2 phosphorylation status at Ser394 and concurrent measurement of deacetylase activity. Additionally, comparative studies between wild-type HDAC2 and phospho-deficient mutants (S394A) can elucidate the direct relationship between this specific phosphorylation event and enzymatic activity.

What is the relationship between HDAC2 Ser394 phosphorylation and inflammatory conditions?

HDAC2 phosphorylation at Ser394 plays a significant role in inflammatory conditions, particularly in steroid resistance observed in chronic inflammatory diseases . Research has established that phospho-acetylation of HDAC2 (phosphorylation at Ser394 followed by acetylation on lysine residues) negatively regulates its deacetylase activity, contributing to the molecular mechanisms underlying steroid resistance .

In inflammatory contexts, oxidative stress appears to be a key mediator affecting HDAC2 phosphorylation. Studies using cigarette smoke extract (CSE) as an oxidative stress inducer have demonstrated altered HDAC2 phosphorylation patterns, suggesting a direct link between redox status and HDAC2 function . This relationship is particularly relevant in respiratory inflammatory conditions like chronic obstructive pulmonary disease (COPD), where oxidative stress is prevalent.

To investigate this relationship, researchers should design experiments examining HDAC2 phosphorylation states in inflammatory versus normal conditions, using appropriate cellular models (such as bronchial epithelial cell lines for respiratory inflammation). Analysis should include assessment of:

  • Phosphorylation status at Ser394 under inflammatory stimuli

  • Correlation between phosphorylation levels and deacetylase activity

  • Impact of anti-inflammatory interventions on HDAC2 phosphorylation

  • Functional consequences of preventing Ser394 phosphorylation in inflammatory response models

How can phosphatase activity modulation be used to study HDAC2 Ser394 phosphorylation dynamics?

Modulating phosphatase activity provides a powerful approach to investigate HDAC2 Ser394 phosphorylation dynamics. Since phosphorylation status represents an equilibrium between kinase and phosphatase activities, manipulating phosphatases offers unique insights into regulatory mechanisms. To implement this approach, researchers can use phosphatase inhibitors like okadaic acid (100 nM) to prevent dephosphorylation and study the natural phosphorylation rate at Ser394 .

For comprehensive analysis of phosphatase involvement, prepare cell lysates in phosphatase storage buffer (50 mM Tris HCl pH 8, 150 mM NaCl, 1% NP40, 0.1% SDS, 0.5% deoxycholate, without phosphatase inhibitors) . Measure phosphatase activity using commercial serine/threonine phosphatase assay kits with phosphopeptide substrates like RRA(pT)VA. To isolate specific phosphatase contributions, remove endogenous phosphate by applying samples to Sephadex G-25 resin columns and centrifuging at 600 × g for 5 minutes at 4°C .

Compare phosphatase activity levels with HDAC2 Ser394 phosphorylation status under various treatment conditions to establish correlation patterns. Additionally, investigate the specific role of PP2A (Protein Phosphatase 2A), which has been implicated in regulating phosphorylation of nuclear proteins including HDACs. This approach helps construct a comprehensive understanding of the dynamic regulation of HDAC2 phosphorylation in different cellular contexts.

What are common challenges in detecting phosphorylated HDAC2 at Ser394 and how can they be addressed?

Detecting phosphorylated HDAC2 at Ser394 presents several technical challenges that researchers should anticipate and address methodically. Common issues include:

  • Low signal intensity: Phosphorylation events are often transient and affect only a fraction of the total protein pool. To enhance detection, optimize cell lysis conditions using buffers containing phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) . Consider phospho-protein enrichment techniques before Western blotting, and use high-sensitivity detection systems such as chemiluminescent substrates with extended exposure times.

  • High background signals: Non-specific antibody binding can obscure phospho-specific signals. Improve specificity by optimizing antibody dilutions (typically 1:500-1:2000 for Western blot) , extending blocking steps (5% BSA in TBST is often more effective than milk for phospho-epitopes), and implementing more stringent washing procedures (additional washes with higher salt concentrations).

  • Phosphorylation instability: HDAC2 Ser394 phosphorylation can be rapidly lost during sample preparation due to endogenous phosphatase activity. Prevent this by processing samples quickly at 4°C and including phosphatase inhibitor cocktails in all buffers. For highly sensitive applications, consider adding okadaic acid (100 nM) to samples immediately upon collection .

  • Antibody cross-reactivity: Phospho-specific antibodies may recognize similar phosphorylated epitopes in other proteins. Validate specificity using phospho-deficient HDAC2 mutants (S394A) as negative controls . Additionally, competing phosphorylation at nearby residues (such as S422 and S424) might affect antibody recognition; use multiple antibody sources or detection methods to confirm results.

How can I distinguish between specific HDAC2 Ser394 phosphorylation and other post-translational modifications?

Distinguishing specific HDAC2 Ser394 phosphorylation from other post-translational modifications requires a multi-faceted approach combining genetic, biochemical, and analytical techniques:

  • Site-directed mutagenesis: Generate phospho-deficient HDAC2 mutants where Ser394 is replaced with alanine (S394A) to prevent phosphorylation specifically at this site . Compare these with wild-type HDAC2 and other phospho-site mutants (S422A, S424A) to isolate Ser394-specific effects. Additionally, create phospho-mimetic mutants (S394D or S394E) to simulate constitutive phosphorylation.

  • Phosphatase treatment: Treat immunoprecipitated HDAC2 with lambda phosphatase to remove all phosphorylation modifications, then compare with untreated samples to determine total phosphorylation contribution. Use specific inhibitors to selectively block certain phosphatases (e.g., okadaic acid for PP2A inhibition) .

  • Mass spectrometry analysis: Implement targeted phospho-proteomics to precisely map all phosphorylation sites on HDAC2. This approach can quantitatively assess the relative abundance of phosphorylation at Ser394 versus other sites under different experimental conditions.

  • Sequential immunoprecipitation: First immunoprecipitate total HDAC2, then perform a second immunoprecipitation with Phospho-HDAC2 (Ser394) antibody to enrich specifically for this phospho-form. Western blotting can then be performed to detect other modifications (acetylation, ubiquitination) that may co-occur with Ser394 phosphorylation.

  • Kinase manipulation: Selectively inhibit or deplete CK2α using specific inhibitors or siRNA approaches, as this kinase has been identified as responsible for Ser394 phosphorylation . This approach helps distinguish CK2-mediated phosphorylation at Ser394 from modifications catalyzed by other kinases.

What factors influence the reproducibility of HDAC2 Ser394 phosphorylation experiments?

Several factors critically influence the reproducibility of HDAC2 Ser394 phosphorylation experiments, requiring careful experimental design and standardization:

  • Cell culture conditions: Growth factors in serum can activate signaling pathways affecting phosphorylation. Standardize serum concentrations and consider serum starvation (6-12 hours) before treatments to establish consistent baseline phosphorylation levels. Cell density and passage number also significantly impact phosphorylation patterns; maintain consistent plating densities (3.0-5.0 × 10^5 cells in 6-well plates) and use cells within a limited passage range .

  • Treatment timing and conditions: HDAC2 phosphorylation is dynamic and time-dependent. Establish detailed time courses for treatments (e.g., 0.5h, 2h, 6h for CSE exposure) to capture peak phosphorylation events . Environmental variables like temperature, pH, and CO2 levels should be strictly controlled during treatments.

  • Lysis conditions: Phosphorylation status can change rapidly during sample processing. Standardize cell lysis protocols by using consistent buffer compositions (0.5% NP-40, 25 mM Tris, 100 mM NaCl with protease and phosphatase inhibitors, pH 7.4), lysis durations (30 minutes on ice), and sample handling procedures . Process all experimental conditions simultaneously to minimize variation.

  • Antibody quality and batch effects: Antibody performance can vary between lots. When possible, complete experimental series using the same antibody lot, and include internal standard samples across blots for normalization. Validate each new antibody lot against known positive controls.

  • Protein load and transfer efficiency: Inconsistent protein loading or variable transfer efficiency can confound phosphorylation analysis. Implement rigorous protein quantification before loading, use consistent protein amounts (typically 20-50 μg for Western blots), and include loading controls (both total HDAC2 and housekeeping proteins) for normalization .

How does HDAC2 Ser394 phosphorylation interact with other post-translational modifications to create a regulatory code?

HDAC2 Ser394 phosphorylation operates within a complex network of post-translational modifications that collectively form a regulatory code determining HDAC2 function. Research indicates that phosphorylation at Ser394 facilitates subsequent acetylation on lysine residues, establishing a phospho-acetylation sequence that fundamentally alters HDAC2 activity . This sequential modification pattern suggests a hierarchical regulatory system where phosphorylation serves as a priming event for additional modifications.

Beyond acetylation, S-nitrosylation represents another significant modification affecting HDAC2 function. Research has identified cysteine residues (Cys-262 and Cys-274) as targets for S-nitrosylation, which can induce HDAC2 release from chromatin in neurons . This raises interesting questions about potential crosstalk between phosphorylation at Ser394 and S-nitrosylation events - whether they operate independently, synergistically, or antagonistically.

To investigate these complex interactions, researchers should implement comprehensive modification mapping using mass spectrometry techniques coupled with site-specific mutant studies. Sequential treatment protocols can help establish modification hierarchies, while proximity ligation assays might identify modification-specific protein interaction partners. This research direction promises to reveal how combinatorial modifications create functionally distinct HDAC2 populations within cells, potentially explaining context-specific functions in different tissues and disease states.

What is the relationship between HDAC2 Ser394 phosphorylation and neurodegenerative disorders?

The relationship between HDAC2 Ser394 phosphorylation and neurodegenerative disorders represents an emerging area of investigation with significant therapeutic implications. HDAC2 has been implicated in neurodegenerative conditions through its regulation of neuronal gene expression and memory formation processes . Phosphorylation at Ser394, which modulates HDAC2's deacetylase activity and interactions with transcription factors, may serve as a critical regulatory mechanism in neuronal function and dysfunction.

In neuronal contexts, HDAC2 post-translational modifications appear to have specialized roles. For example, S-nitrosylation of HDAC2 in neurons induces its release from chromatin without affecting enzyme activity, subsequently increasing acetylation of histones surrounding neurotrophin-dependent gene promoters . This raises the possibility that phosphorylation at Ser394 might interact with neuronal-specific modification patterns to regulate HDAC2 function in brain tissues.

To explore this relationship, researchers should:

  • Compare HDAC2 Ser394 phosphorylation patterns in brain tissues from neurodegenerative disease models versus controls

  • Examine how neuronal stimulation affects HDAC2 phosphorylation

  • Investigate potential crosstalk between Ser394 phosphorylation and neuronal-specific modifications like S-nitrosylation

  • Assess how modulating HDAC2 phosphorylation affects neuronal gene expression patterns, particularly genes implicated in neurodegeneration

How can phosphorylation-specific antibodies like Phospho-HDAC2 (Ser394) be integrated with advanced imaging techniques for in situ analysis?

Integrating phosphorylation-specific antibodies like Phospho-HDAC2 (Ser394) with advanced imaging techniques offers powerful approaches for in situ analysis of phosphorylation dynamics at cellular and subcellular levels. This integration requires careful optimization of protocols to maintain phospho-epitope integrity while achieving high-resolution visualization.

For super-resolution microscopy applications, researchers should optimize fixation protocols specifically for phospho-epitope preservation. Paraformaldehyde fixation (4%, 10-15 minutes) followed by methanol post-fixation (-20°C, 10 minutes) often yields superior results for phosphorylated nuclear proteins. When implementing immunofluorescence detection, use higher antibody concentrations than for Western blotting (typically starting at 1:200-1:500 dilutions) and extend incubation times (overnight at 4°C) .

To achieve multiplexed detection of different HDAC2 modifications simultaneously, consider sequential immunostaining protocols with careful antibody stripping between rounds, or implement spectral unmixing approaches with fluorophores having distinct emission profiles. For live-cell imaging of phosphorylation dynamics, phospho-specific intrabodies or FRET-based biosensors could be developed, though these would require extensive validation against the established Phospho-HDAC2 (Ser394) antibodies.

The combination of phospho-specific immunodetection with proximity ligation assays (PLA) offers particularly powerful insights, enabling visualization of specific interaction partners of phosphorylated HDAC2 within intact cells. This approach could reveal spatial and temporal patterns of phosphorylation-dependent interactions that are lost in biochemical assays, providing unprecedented insights into the functional consequences of HDAC2 Ser394 phosphorylation in different cellular compartments and physiological contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.